Authors: H L Duan, J Peng, N Pang, S M Chen, J Xiong, S Q Guang, F Yin
Publication Date: May 2019
Link to article: https://pubmed.ncbi.nlm.nih.gov/31060130/
Research Explained Summary:
This publication is a case report of an individual with OCNDS that has the c.524A>G (p.D175G) variant in the
CSNK2A1 gene and is the first report of OCNDS in the mainland of China. The patient was a 1 year and 8-month-old boy with symptoms that included microcephalus (small head), broad nasal bridge, micrognathia (small lower jaw), and hypotonia. The authors then summarized the clinical findings of OCNDS at the time of publication, which included mostly individuals with missense changes (a genetic alteration that occurs when a single base pair in DNA is substituted, resulting in a different amino acid being incorporated into a protein) in the
CSNK2A1 gene, with the K198R change being the most common.
We are focused on finding a cure for Okur-Chung Neurodevelopmental Syndrome and ensuring affected individuals have the opportunities and supports necessary for happy and full lives.
CSNK2A1
Foundation is operated and funded through a committed team of volunteers, advocates and researchers.
We are a 501(c)(3) non-profit organization.
EIN #82-4220939.
Address: 1929 Van Ness Avenue, San Francisco, CA 94109
Phone:
(415) 501-0147
Email:
info@csnk2a1foundation.org
The information provided is not intended to be a substitute for professional medical advice, diagnosis or treatment. Never disregard professional medical advice, or delay in seeking it, because of something you have read on this website. Read more...
All Rights Reserved | CSNK2A1 Foundation